Microvascular system

The microvascular system is the complex network of the body's smallest blood vessels, including arterioles, capillaries, and venules, which serve as the primary site for the exchange of oxygen, nutrients, and metabolic waste between the blood and tissues (StatPearls, 2023). It plays a fundamental role in maintaining tissue homeostasis, regulating systemic blood pressure through peripheral resistance, and facilitating the recruitment of immune cells during inflammatory responses (NIH, 2022). Dysfunction of the microvasculature, often termed microangiopathy, is a critical driver in the progression of chronic conditions such as diabetic retinopathy, nephropathy, and various forms of heart failure (PubMed, 2021). While the microvascular system is a physiological compartment rather than a single molecular target, it is the functional site of action for many therapeutic classes. Drugs targeting this system include anti-angiogenic agents used to treat cancer and macular degeneration by inhibiting Vascular Endothelial Growth Factor (VEGF), as well as vasodilators used to manage hypertension and pulmonary vascular resistance (PubChem, 2024). Therapeutic strategies often focus on restoring endothelial function, reducing vascular permeability, or preventing the rarefaction of capillary beds to preserve organ function. Understanding the microvascular environment is essential for biotech analysts evaluating treatments for ischemic, metabolic, and inflammatory diseases.

Other names

MicrovasculatureMicrocirculationTerminal vascular bedCapillary network

Drugs modulate the microvascular system through several distinct pathways: vasodilators (e.g., nitrates and calcium channel blockers) act on smooth muscle cells to increase vessel diameter and flow; anti-angiogenic agents (e.g., VEGF inhibitors) block growth factor signaling to prevent pathological vessel proliferation; and ACE inhibitors reduce hydrostatic pressure to prevent capillary barotrauma (StatPearls, 2023; FDA, 2024).